PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CHU de Caen, Department of Infectious Diseases, Avenue de la Côte de Nacre, Caen F-14000, France. Electronic address: baldolli-a@chu-caen.fr.\', \'CHU de Caen, Department of Infectious Diseases, Avenue de la Côte de Nacre, Caen F-14000, France.\', \'Fondation Hospitalière de la Misericorde, Caen F-14000, France.\', \'CHU de Caen, Department of Infectious Diseases, Avenue de la Côte de Nacre, Caen F-14000, France; Groupe de Recherche sur l\'Adaptation Microbienne (GRAM 2.0), Université Caen Normandie, Caen F-14000, France.\', \'CHU de Caen, Departments of Biostatistics and Clinical Research, Avenue de la Côte de Nacre, Caen F-14000, France; Groupe de Recherche sur l\'Adaptation Microbienne (GRAM 2.0), Université Caen Normandie, Caen F-14000, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00804-510.1016/j.vaccine.2021.06.054
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34210574
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all